Company Intelligence

Due diligence intelligence for active companies. Signal-scored across geopolitical exposure, regulatory risk, and sector tailwinds — ranked by composite risk/opportunity score.

Filters:🇩🇪 Germany ✕

All energy technology financials healthcare industrials consumer materials utilities defense semiconductors mining pharma telecom shipping agriculture real_estate

All postures ✦ Opportunities ⚠ Risks

Related Investment Themes

🧠AI Chip Bottleneck 🛡US Defense Surge 🚢Red Sea Escalation ⚓Shipping Lane Fragmentation 🔌Taiwan Semiconductor Risk 🏗India Infrastructure Supercycle

Total Tracked

Opportunities

Risk Flags

No data

✦

Opportunities

(0)

Ticker

Company

Sector

Action

Flag

Score

No opportunities in this filter

⚠

Risks

(4)

Ticker

Company

Sector

Action

Flag

Score

IFNNY

🇩🇪Infineon Technologies AG

Infineon's automotive exposure is a structural headwind as E

Infineon's automotive exposure is a structural headwind as European OEMs lose share to Chinese EV ma

Infineon's automotive exposure is a structural headwind as European OEMs lose share to Chinese EV manufacturers using domestic power semicon

semiconductors

AVOID

🇩🇪Deutsche Bank AG

Deutsche Bank's German corporate book is exposed to a deepen

Deutsche Bank's German corporate book is exposed to a deepening industrial recession, with EV slowdo

Deutsche Bank's German corporate book is exposed to a deepening industrial recession, with EV slowdown and energy-intensive industries delev

financials

AVOID

🇩🇪

-43—

VWAGY

🇩🇪Volkswagen AG

Volkswagen faces existential restructuring with potential Ge

Volkswagen faces existential restructuring with potential German plant closures (first in 87-year hi

Volkswagen faces existential restructuring with potential German plant closures (first in 87-year history), works council confrontation, and

consumer

AVOID

🇩🇪

-32—

BAYRY

🇩🇪Bayer AG

Bayer remains structurally impaired by Roundup litigation th

Bayer remains structurally impaired by Roundup litigation that the new CEO's plan has not resolved.

Bayer remains structurally impaired by Roundup litigation that the new CEO's plan has not resolved. Xarelto LOE is hitting hard with no Phar

pharma

AVOID

🇩🇪

-22—